{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:40:04Z","timestamp":1756276804345,"version":"3.44.0"},"reference-count":5,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\n                  <jats:bold>Overview of:<\/jats:bold> Butler J, Anker SD, Lund LH, <jats:italic>et al<\/jats:italic>. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. <jats:italic>Eur Heart J<\/jats:italic> 2022. doi:10.1093\/eurheartj\/ehac401 [Epub ahead of print, 2022 Jul 28].<\/jats:p>","DOI":"10.1136\/dtb.2022.000063","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T13:20:59Z","timestamp":1668432059000},"page":"182-182","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Patiromer for hyperkalaemia in heart failure"],"prefix":"10.1136","volume":"60","member":"239","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"2025082623054462000_60.12.182.1","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1093\/eurheartj\/ehac401","article-title":"Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J"},{"key":"2025082623054462000_60.12.182.2","unstructured":"Veltassa (Patiromer) 8.4 g powder for oral suspension . Summary of product characteristics, GB. Vifor Fresenius Medical Care Renal Pharma France, 2022."},{"key":"2025082623054462000_60.12.182.3","unstructured":"National Institute for Health and Care Excellence . Patiromer for treating hyperkalaemia (TA623) [online], 2020. Available: https:\/\/www.nice.org.uk\/guidance\/ta623 [Accessed 1 Nov 2022]."},{"key":"2025082623054462000_60.12.182.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410853"},{"key":"2025082623054462000_60.12.182.5","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1093\/eurheartj\/ehac399","article-title":"Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial","volume":"43","author":"Packer","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2022.000063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:05:56Z","timestamp":1756274756000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2022.000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":5,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,11,30]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/dtb.2022.000063"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2022.000063","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2022,11,14]]}}}